Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-22
1999-09-21
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530345, 530350, 530380, 424 169, 424 93, G01N 33566
Patent
active
059554371
ABSTRACT:
Detectably labelled annexines and compositions thereof are disclosed. Also disclosed are methods for diagnosing a disruption or activation of the hemostatic system or a prothrombotic state in an individual suspected of having a hemostatic disorder, by contacting the blood of said individual with an annexine, and detecting whether an annexine-platelet complex is formed.
REFERENCES:
patent: 3933996 (1976-01-01), Charlton et al.
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4416865 (1983-11-01), Rhodes et al.
patent: 4427646 (1984-01-01), Olexa et al.
patent: 4455290 (1984-06-01), Olexa et al.
patent: 4659839 (1987-04-01), Nicolotti et al.
patent: 4736018 (1988-04-01), Reutelingsperger
patent: 4820505 (1989-04-01), Ginsberg et al.
patent: 4937324 (1990-06-01), Fujikawa et al.
patent: 5066787 (1991-11-01), Reutelingsperger
patent: 5066788 (1991-11-01), Reutelingsperger
patent: 5118610 (1992-06-01), Kitto
Bevers, E.M. et al., "Changes in Membrane Phospholipid Disribution During Platelet Activation", Biochim. Biophys. Acta 736:57-66 (1983).
Concha et al., "Rat Annexin V Crystal Structure: Ca.sup.2+ -Induced Conformational Changes", Science 261:1321-1324 (Sep. 3, 1993).
Crompton, M.R. et al., "Diversity in the Lipocortin/Calpactin Family", Cell 55:1-3 (Oct. 7, 1988).
Funakoshi, T. et al., "Primary Structure of Human Placental Anticoagulant Protein", Biochemistry 26(25):8087-8092 (1987).
Geisow, M.J., "Common Domain Structure of Ca.sup.2+ and Lipid-Binding Proteins", FEBS Lett. 203(1):99-103 (Jul., 1986).
Geisow, M.J. et al., "Localization and Structure of Novel Calcium-Regulated Phospholipid-Binding Proteins", Biochem. Soc, Trans. 25:800-802 (1987).
Hauptmann & Reutelingsperger, "Molecular Biology and Biochemistry of Annexins V and VIII", Portland Press Res. Monogr. 2:139-150 (1992).
Kaetzel, M.A. et al., "Differential Tissue Expression of Three 35-kDa Annexin Calcium-Dependent Phospholipid-Binding Proteins", J. Biol. Chem. 264(24):14463-14470 (Aug. 25, 1989).
Maurer-Fogy, I. et al., "Cloning and Expression of cDNA for Human Vascular Antiocoagulant, a Ca.sup.2+ -Dependent Phospholipid-Binding Protein", Eur. J. Biochem. 174(4):585-592 (Jul., 1988).
Tait, J.F. et al., "Placental Anticoagulant Proteins: Isolation and Comparative Characterization of Four Members of the Lipocortin Family", Biochemistry 27(17):6268-6276 (Aug. 23, 1988).
Tait, J.F. et al., "Phospholipid Binding Properties of the Human Placental Anticoagulant Protein-I, a Member of the Lipocortin Family", J. Biol. Chem. 264(14):7944-7949 (May 15, 1989).
Thiagarajan and Tait, "Binding of Annexin V/Placental Anticoagulant Protein I to Platelets", J. Biol. Chem. 265:17420-17423 (Oct. 15,1990).
International Search Report for the Related International Application No. PCT/EP 90/02257.
Derwent Abstract for German Patent Application Publications No. DE 3810331, Reference AL1.
Derwent Abstract for European Patent Application Publication No. EP 0 181 465, Reference AP1.
Derwent Abstract for European Patent Application Publication No. EP 0 293 567, Dec. 7, 1988.
Derwent Abstract for European Patent Application Publication No. EP 0 318 703, Jun. 7, 1989.
Derwent Abstract for European Patent Application Publication No. EP 0 409 053, Jan. 23, 1991.
Zubay, "Biochemistry" pp. 169 & 171 (1983) Brown Publishers, Dubuque, Iowa.
Boehringer Ingelheim International GmbH
Delaney Patrick R.
Tsang Cecilia J.
LandOfFree
Use of an anticoagulant as a diagnostic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of an anticoagulant as a diagnostic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an anticoagulant as a diagnostic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80292